Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-25-337052

Chief Legal Officer sold 65,000 shares at $38.70 ($2,515,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kearns Evan Chief Legal Officer 2025-12-26 Sale −65,000 $38.70 $2,515,500 109,398 D
Open-market sales · 65,000 sh · avg $38.70 · $2,515,500
Loading xslF345X05/ownership.xml…